Results 1 to 10 of about 937 (62)

First-in-Human Phase I Study of KPT-9274, a First-in-Class Dual Inhibitor of PAK4 and NAMPT, in Patients with Advanced Solid Malignancies. [PDF]

Target Oncol
Razak A, Mahipal A, Diamond JR, Ribas A, Berlin JD, Azmi AS, Mark T, Walker CJ, Chai Y, Kashyap T, Gudi G, Naing A.   +11 more
europepmc   +1 more source

Xyloglucan xylosyltransferase stem region mediates heterodimer formation. [PDF]

Nat Commun
Julian JD, Zhang N, Winders RJ, Stewart CE, Culbertson AT, Zabotina OA.   +5 more
europepmc   +1 more source

NAPRT, but Not NAMPT, Provides Additional Support for NAD Synthesis in Esophageal Precancerous Lesions. [PDF]

Nutrients, 2022
Wang N, Pan D, Wang X, Su M, Wang X, Yan Q, Sun G, Wang S.   +7 more
europepmc   +1 more source

Engineered tumor-tropic mesenchymal stem cells as targeted therapeutic delivery systems for refractory Ovarian cancer. [PDF]

J Control Release
Li G, Massumi M, Owji H, Yang G, Girda E, Hatefi A.   +5 more
europepmc   +1 more source

RETINAL MANIFESTATIONS OF WALKER-WARBURG SYNDROME IN TWO SIBLINGS WITH RXYLT1 MUTATIONS. [PDF]

Retin Cases Brief Rep
Jung EE, Nagiel A.
europepmc   +1 more source

Deazaguanylation is a nucleobase-protein conjugation required for type IV CBASS immunity. [PDF]

Science
Wassarman DR, Pfaff P, Paulo JA, Gygi SP, Shokat KM, Kranzusch PJ.   +5 more
europepmc   +1 more source

Molecular evolution of nucleoside deoxyribosyl transferase to enhance the activity toward 2'-fluoro-2'-deoxynucleoside. [PDF]

J Ind Microbiol Biotechnol
Yang SB, Yoo YJ, Choi K, Kim B, Choi SS, Kang SH, Kim ES.   +6 more
europepmc   +1 more source

Xylosyltransferase-II deficiency rewires innate immune signaling and destabilizes polarization in human macrophages. [PDF]

Front Immunol
Witt A, Ly TD, Kühle M, Knabbe C, Faust-Hinse I.   +4 more
europepmc   +1 more source

De novo NAD⁺ synthesis is ineffective for NAD⁺ supply in axenically cultured Caenorhabditis elegans. [PDF]

Commun Biol
Zhu S, Zhang R, Yao L, Lin Z, Li Y, Li S, Wu L.   +6 more
europepmc   +1 more source

Ribitol and ribose treatments differentially affect metabolism of muscle tissue in FKRP mutant mice. [PDF]

Sci Rep
Cataldi MP, Lu QL.
europepmc   +1 more source